WHO sets up TB drug procurement agency

25 March 2001

The World Health Organization has launched a new procurement agency toimprove access to tuberculosis drugs in developing countries. To be financed by donations, the Global TB Drug Facility will be a mechanism for ensuring increasing access to high-quality drugs, said WHO spokesman Ian Smith, reported by Reuters.

Drug shortages are a major problem for TB patients, he said, noting that only about 25% of patients worldwide are treated in the Directly-Observed Treatment, Short-course (DOTS) program.

Also, the Bill and Melinda Gates Foundation is to provide $10 million over five years for work being done under WHO auspices to develop TB diagnostic tests.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight